Suzhou JiWan Gene Biotechnology, Co., Ltd. is a biotechnology company that uses insect cells to produce rAAV gene vectors on a large scale, and provides related services. We possess AAV precision packaging technology, AAV large gene packaging technology, AAV gene-editing technology, and other world-leading technologies.
Our strengths include AAV knowledge, AAV vector technologies, a talented team, domestic and international patents, and pioneering minds.
Our Understanding of AAV Our Technology Our Team Our Intellectual Property Our Innovation |
AAV vectors are the main tool used for gene therapy and gene editing. However, the current understanding of AAV is insufficient, and some fundamental issues have not been resolved. At the moment, there are problems with AAV vector quality and mass production. Thus, there are still big challenges with the application of AAV vectors!
Our company has independently developed multiple innovative AAV vector technologies:
1. AAV vector precision packaging technology: not only can it reduce packaging impure DNA to zero, this technology can also control and use integrated DNA.
2. AAV large gene packaging technology: enables genes packaged in rAAV vectors to reach 6.0-7.0 kb. Currently, the technology is being further developed for genes over 9.0 kb in size.
3. AAV efficient gene editing technology: Production of lgAAV CRISPR/CAS9 gRNA by AAV large gene packaging technology is efficient and simple, and can be effectively applied to in vivo gene editing.
Our team is composed of world-class, AAV leading scientists. Committed to high-quality, high-yield AAV vector production, we provide one-stop solutions to worldwide challenges in AAV vector production and application. We offer customers 24/7 pre-sales, in-sales, and after-sales services of the best quality.
Through long-term, innovative research and development, we have established our patented technology and have applied for multiple breakthrough Chinese patents and PCT patents.
The founder of our company is a leading researcher of AAV. He is skilled in applying the theoretical knowledge of AAV to solve practical problems in AAV vector production, AAV gene therapy, and AAV gene editing, and is constantly innovating.
|
|